inoa inoaulaglutide - hoʻonā i PBS / dulaglutide
Helu CAS.:923950-08-7
Helu Hui :GT-F002
Sequence: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Gl y-Gly-OH
Kumu molekala: C149H221N37O49
Kaumaha molekula: 3314.62
ʻO Dulaglutide CAS NO.923950-08-7.jpg
Nā hōʻailona ʻenehana:
ʻAno keʻokeʻo pauda
ʻO ka maʻemaʻe (HPLC) he ≥95.0%
ʻO ka heterozygosity hoʻokahi i emi iho ma mua o 2.0%
Mai ka 5.0% a i ka 12.0% ka nui o ka waikawa Acetic.
ʻO ≤10.0% ka moisture content
ʻO ka maʻiʻo peptide he ≥80.0%
Hoʻopili a me ka hoʻouna ʻana:
ʻO ka wela haʻahaʻa, ka pahu pahu, pololei i ka milligram ma ke noi.
Hōʻike huahana:
ʻO Durraglutide kahi agonist GLP-1R hou lōʻihi, i loaʻa mai ka hui ʻana o ʻelua DPP-4 inhibitory GLP-1 analogues a me ke kanaka immunoglobulin kaumaha kaulahao IgG4-Fc.Ua like kāna hana me ka GLP-1 endogenous i nā hōʻike lapaʻau, me ka hapalua o ke ola o 5 mau lā, a hiki ke hoʻopaneʻe maikaʻi i ka hoʻomaʻemaʻe renal.Ua ʻae ka FDA i ka dulaglutide no ka hoʻokele subcutaneous ma Kepakemapa 2014.
Waihona: Hoʻomaloʻo maloʻo ma -20 ℃ a mālama ʻia mai ka mālamalama
Manaʻo: No ka noiʻi wale nō, ʻaʻole no nā kumuhana kanaka
Ka manawa hoʻouna: Oct-13-2023